Obesity
Conference Coverage
When low HDL means ‘no sweat’
Major finding: Adults with low HDL cholesterol coupled with an LDL cholesterol below 100 mg/dL and a triglyceride level below 100 mg/dL had a very...
News
Increasing maternal BMI raises fetal, infant death risk
Major finding: Even modest increases in maternal BMI were associated with increases in the risk of every category of infant mortality; the...
News
Diet, exercise in prediabetes may prevent long-term progression and mortality
Major finding: At 23-year follow-up, the intervention group had a 41% lower risk of cardiovascular disease mortality, a 29% lower risk of all-...
News
Diabetes prevalence increases, but so does diabetes control
Major finding: The prevalence of diagnosed diabetes in the United States rose significantly, from 6%-10% from 1988-2010.Data source: The findings...
Conference Coverage
ACC/AHA cardiovascular risk equations get a thumbs-up
Major finding: The controversial cardiovascular risk equations at the heart of the latest ACC/AHA risk-assessment guidelines turned in a moderate...
News
Stress cardiac magnetic resonance feasible and prognostic in obese patients
Major finding: Obese individuals with no evidence of inducible ischemia or LGE in stress CMR are at significantly lower annualized risk of MACE (0...
Conference Coverage
'Favorable signal' for secondary coronary prevention in STABILITY
Major finding: The combined rate of cardiovascular death, myocardial infarction, or stroke in patients randomized to darapladib was 9.7%, yielding...
Conference Coverage
VIDEO: PCSK9 inhibitors placed in perspective
News
One in four patients with hypertension nonadherent to therapy
Major finding: A urine test available to commercial labs showed that 25% of patients were totally (10.1%) or partially (14.9%) nonadherent to...
Conference Coverage
Bariatric surgery’s benefit persists in type 2 diabetes
Major finding: Significantly more patients treated with one of two types of bariatric surgery achieved the HbA1c target (37.5% and 24.5%) after 3...
Conference Coverage
Evolocumab betters ezetimibe for lowering LDL in statin-intolerant patients
Major finding: Statin-intolerant patients with hypercholesterolemia experienced mean 53%-56% reductions in LDL cholesterol in response to 12 weeks...